Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 7/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12171156 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1PDK2DUSP3 | |
| SCHEMBL12292088 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1PDK2DUSP3 | |
| SCHEMBL390193 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1PDK2DUSP3 | |
| SCHEMBL29664894 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1PDK2DUSP3 | |
| SCHEMBL30077228 | 0.95 | KDM4E (0.46) | KDM4EATML3MBTL1PDK2DUSP3 | |
| SCHEMBL24667553 | 0.92 | KDM4E (0.41) | KDM4EATML3MBTL1PDK2DUSP3 | |
| SCHEMBL17854687 | 0.91 | KDM4E (0.42) | KDM4EATML3MBTL1PDK2DUSP3 | |
| SCHEMBL17854692 | 0.91 | KDM4E (0.42) | KDM4EATML3MBTL1PDK2DUSP3 | |
| SCHEMBL601646 | 0.91 | KDM4E (0.50) | KDM4EATML3MBTL1PDK2DUSP3 | |
| SCHEMBL30293940 | 0.91 | KDM4E (0.50) | KDM4EATML3MBTL1PDK2DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10707423-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-07-07 | — | — | US | disclosed |
| US-20150243894-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-08-27 | — | — | US | disclosed |
| US-20150243894-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10707423-B2 | Organic electroluminescent materials and devices | OCIAD1, OXA1L, SLCO2B1 | KDM4E 3237/4885ATM 3925/4885L3MBTL1 517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.